The Mason-Assurex Research Science Seminar Series is a collaborative partnership between the City of Mason, Ohio, and Assurex Health, a wholly owned subsidiary of Myriad Genetics Inc. Together we seek to educate, inspire and nurture current employees, future talent and the Ohio community by offering a diversity of perspectives and new ideas in scientific research and practice, access to cutting-edge science and scientists. Assurex Health-Myriad and the City of Mason are proud to present this seminar series as part of our People First initiative.
Dr. Alan Schatzberg from the Stanford University School of Medicine will be joining Assurex for the first installment of our Science Seminar Series for 2017.
The efforts to predict positive response to antidepressants has proved to be less productive than have predicting tolerability. We reviewed studies from our group over the past 15 years and emphasize recent data on MDR-1 as a differential predictor to specific agents. Possible studies to clarify applications are discussed.
The event will take place on the 1st Floor of the Municipal Building, but please register for the webinar if you cannot attend in person.